When it comes to manufacturing, Erixon sees the market as trickier ... integrated supply chain for active pharmaceutical ingredients (APIs) and finished medicines, any disruption could affect ...

Currently, India imports both raw materials—mostly crude oil—and finished goods ... include engineering goods, electronic products, gems and jewellery, drugs and pharmaceuticals, petroleum ...

President Trump's 25% tariffs on goods from Canada and Mexico are expected to have a significant impact on the auto industry ... multiple times before a finished vehicle rolls off the assembly ...

"Higher tariffs will raise prices of imported goods ... 0% drag on pharmaceutical manufacturing production" because imports of final pharmaceutical products don't have a sizable market share ...

Revenue of our innovative products getting traction, so AUSTEDO as you can see, we've consistently executed that and finished ... effective pharmaceutical medicines to the U.S. market, which ...

The industry reacted to Trump's move at midnight to put 25% tariffs — the taxes paid on products when they cross international borders — on goods coming ... times before a finished vehicle ...

Other products such as pharmaceuticals for livestock and ... If tariffs were limited to just finished goods, that would be less damaging than if they were applied to inputs, or the components ...

84%) are intermediary goods shipped to the US to be finished in US factories, by US workers, thereby adding value to the US economy.” A spokesperson for the Irish Pharmaceutical Healthcare ...

Washington | The US trade deficit widened to a record high in January amid front-loading of imports ahead of tariffs, suggesting that trade could be a drag on economic growth in the first quarter.

For now, the overall labor market continues ... mostly reflecting finished metal shapes, probably gold. Consumer goods imports rose $6.0 billion, boosted by pharmaceutical preparations, cell ...

2025 Wall Street stocks finished lower on Thursday, with the Nasdaq confirming it has been in a correction since December, weighed down by market jitters over the current uncertainty surrounding U ...